Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cardiovascular phenotypes in type 2 diabetes: Latent class analysis of the CANVAS Program and CREDENCE trial.

Diabetes, obesity & metabolism - 1 Nov 2024

Razaghizad Amir, Ni Jiayi, Marques Pedro, Mavrakanas Thomas A, Tsoukas Michael A, Possik Elite, Huynh Thao, Edwards Jodi D, Liu Peter, Swardfager Walter, Baroz Frederic, Ferreira João Pedro, Sharma Abhinav

Abstract excerpt

AIM: To identify unique clinical phenotypes in type 2 diabetes (T2D) and investigate their treatment response to canagliflozin using latent class analysis. METHODS: This was a pooled latent class analysis of the individuals in the CANVAS Program and CREDENCE trial. The co-primary endpoints were hospitalization for heart failure (HHF) and the composite of cardiovascular death (CVD) or HHF. Secondary endpoints...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Diabetic Angiopathies

Share to Heart Failure

Share to Latent Class Analysis

Share to Phenotype

Share to Prevalence

Source

Identifiers

PMID: 39301712
DOI: 10.1111/dom.15768

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cardiovascular phenotypes in type 2 diabetes: Latent class analysis of the CANVAS Program and CREDENCE trial.PMID 39301712Read ↗

Patient Phenotypes and SGLT-2 Inhibition in Type 2 Diabetes: Insights From the EMPA-REG OUTCOME Trial.Semantic proximity Read ↗

Rationale and design of the Brazilian Diabetes Study: a prospective cohort of type 2 diabetesSemantic proximity Read ↗

Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes.Semantic proximity Read ↗

Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine.Semantic proximity Read ↗

Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment Strategies.Semantic proximity Read ↗

Type 2 Diabetes Sub-Phenotypes and Their Association with Cardiovascular Disease Risk: A Multi-Center StudySemantic proximity Read ↗

Data-driven cardiometabolic phenogroups reveal distinct subclinical cardiac and proteomic profilesSemantic proximity Read ↗

Phenotypic heterogeneity of type 2 diabetes and risks of complications with a tree-like representation.Semantic proximity Read ↗

[Phenotypic Classification of Diabetes: A Personalized Approach for Pharmaceutical Practice].Semantic proximity Read ↗

Systematic review of precision subclassification of type 2 diabetesSemantic proximity Read ↗

Identifying and ranking novel independent features for cardiovascular disease prediction in people with type 2 diabetesSemantic proximity Read ↗

Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.